Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rxo (RXO) Revenue (2021 - 2025)

Rxo's Revenue history spans 5 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Revenue fell 11.88% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $5.7 billion, up 26.2%, while the annual FY2025 figure was $5.7 billion, 26.2% up from the prior year.
  • Revenue reached $1.5 billion in Q4 2025 per RXO's latest filing, up from $1.4 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.7 billion in Q4 2024 to a low of $913.0 million in Q1 2024.
  • Average Revenue over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2021.
  • Peak YoY movement for Revenue: dropped 23.02% in 2023, then surged 70.45% in 2024.
  • A 5-year view of Revenue shows it stood at $1.3 billion in 2021, then fell by 15.6% to $1.1 billion in 2022, then fell by 12.68% to $978.0 million in 2023, then soared by 70.45% to $1.7 billion in 2024, then dropped by 11.88% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Revenue are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).